Reference
|
Lopinavir/Ritonavir (Kaletra) 200mg/50mg Tablet
Lopinavir/Ritonavir (Kaletra) 80mg/20 mg per mL Syrup
|
Hydroxychloroquine Sulphate 200 mg
(Plaquenil or Uniquin)
|
Ribavirin 200 mg
(Copegus)
|
|
Hospital Kuala Lumpur [HKL]
Updated 20.03.20
|
Age 14 days to 6 months:
Lopinavir component 16 mg/kg BD (or 0.2 mL/kg BD)
Age 6 months to 18 years:
·
15-25 kg: 200mg/50mg 2.5mL
syrup or 1 tab BD
·
26-35 kg: 300 mg/75 mg
(3.75mL) BD
·
>35 kg: 400 mg/100 mg
5mL or 2 tabs BD
|
<18 years:
10 mg/kg (max: 400 mg/dose) BD x 1 day
then 3 mg/kg (max: 200 mg/dose) BD
|
-
|
|
Hospital Umum Sarawak [HUS]
Updated 23.03.20
|
2wk – 6 mth:
16mg/4mg LPV/r per kg BD
(0.2 mL/kg BD)
6 months – 18 years:
§
7 to <15kg: 12mg/kg/dose
BD (0.15 mL/kg BD)
§
15-40kg: 10mg/kg/dose BD
(0.125 mL/kg BD) ; Max 400mg/100mg BD
§
>40kg: As per adult
dosing: 2 tabs BD or 5 mL BD
|
Tablet / Extemporaneous suspension:
Day 1: 5-6 mg/kg/dose BD (Max 400mg/dose)
Day 2-5: 1.5-3 mg/kg/dose BD (Max 200mg/dose)
Prepare oral suspension of 25mg/ml:
15 tabs to 120ml of X-temp. Keep in amber bottle,
stable at room temperature (25 ± 2°C) for 90 days.
|
-
|
|
UptoDate:
Refer to Drug Information for each individual drug(s)
Accessed 13.04.2020
|
Lopinavir/ritonavir
is currently under investigation for use in the treatment of coronavirus
disease 2019 (COVID-19). At this time, safety and efficacy have NOT been
established in adult or pediatric patients.
|
Hydroxychloroquine
sulfate 200 mg is equivalent to 155 mg hydroxychloroquine base.
Children and Adolescents:
Oral: 6.5 mg/kg/dose twice daily on day 1; maximum
day 1 dose: 400 mg/dose; followed by 3.25 mg/kg/dose twice daily on days 2
through 5; maximum dose: 200 mg/dose (ASTCT 2020)
Note:
These dosing recommendations are specifically
for patients who have undergone
hematopoietic cell transplant (HCT) or other cellular therapy. However,
some centers are reporting internal protocols/plans to use this dose in
hospitalized pediatric patients who are not HCT patients.
|
At
this time, while there are a number of medicines being investigated for
treatment and/or prevention of COVID-19, none have yet to demonstrate safety
and efficacy in humans diagnosed with or exposed to COVID-19.
|
|
An Algorithmic Approach to Diagnosis and Treatment
of Coronavirus
Disease 2019 (COVID-19) in Children: Iranian
Expert’s Consensus
Statement
Updated 05.03.20
|
All
dosing based on lopinavir:
14 days to 12 months:
16 mg/kg/dose BD PO or
300 mg/m2/dose BD PO
12 months to 18 years:
v
Based on BSA:
230 mg/m2/dose BD PO (max 400 mg
BD PO)
v
Based on weight:
Ø Less than 15 kg: 12 mg/kg/dose BD PO
Ø 15-40 kg: 10 mg/kg/dose BD PO
Ø Greater than 40 kg: 2 tabs BD
PO (1 tab = 200/50)
|
IV, hydroxychloroquine sulfate:
Infants and children
3-5 mg/kg/day (max dose 400 mg), BID For 5 days
[No oral HCQ recommendation, only IV available]
|
Over 3 years old:
ü
< 47 kg: 7.5 mg/kg BD
ü
47-59 kg: 400 mg BD
ü
60-73 kg: 400 mg OM,
600 mg ON
ü
> 73 kg: 600 mg BD
For up to 14 days, depends on patient’s response.
|
|
Michigan Medicine: Emergency Department Guidance for
Treatment of COVID-19 in Adults and Children
Updated 25.03.20
|
-
|
All doses are for < 18 years old.
Admitted
/ Pending admission:
*10 mg/kg (max: 600 mg/dose)
PO BID x2 (load), then 3 mg/kg PO TID (max: 200 mg/dose)
*Minimum
5 days; may be extended if slow clinical improvement or clinical worsening
Discharged from emergency
department:
*8
mg/kg PO BID x2 doses (max: 400 mg/dose), then 4 mg/kg PO BID (max: 200
mg/dose)
*Total
5 days
|
-
|
|
Caution(s) / Remark(s)
|
Dispense in amber bottles.[HUS]
May consume with sweets or
tangy food (e.g. orange juice, chocolate syrup) to improve palatability.[HUS]
Caution: Syrup contains
42.4% ethanol and 15.3% ethylene glycol, hence potentially incompatible with
polyurethane feeding tubes [HKL]
Hence
for oral solution (NG tube feeding): Only use silicone & polyvinyl
chloride (PVC) feeding tube. [HKL/HUS]
Administer
UNDILUTED / PURE. Rinse feeding tube with milk (NOT water). [HKL/HUS]
For adult or child > 40
kg that uses tablet in tube feeding:
Exposure
of Lopinavir can be reduced by 45% when the tablet is crushed
May
increase to 3 or 4 tabs BD x 10-14 days [HKL/HUS]
Caution with GI symptoms and
liver function [HUS]
Generally for 5 - 14 days,
depends on physician’s judgment.[Iran]
|
Tablet can be crushed and
dispersed in water.[HUS]
ECG prior to starting
chloroquine and after onset of drug, cardiac monitoring is recommended [Iran]
Use with caution in patient
at risk for QT prolongation [Michigan]
|
For NG tube
feeding: Tablet can be crushed. However use double glove and protective gown, as
drug has teratogenic potential to
men and women trying to conceive (Ensure precautionary notes is attached).[HUS]
|
|
May
enhance QT-prolonged effect when ≥2 of the following administered together:
AMIODARONE,
Azithromycin, Ciprofloxacin, Fluconazole, Chloroquine,
Hydroxychloroquine, Kaletra®
|
|
|||
* Off-label Treatment
Patient Consent Form is needed.
* So far there is no
established paediatric dosing of ribavirin, interferon beta 1b and
tocilizumab for COVID-19.
|
Updated 13.04.2020 by JCK Ho (Hospital Keningau)
|
|||
ANYHOW
THIS IS JUST A ROUGH GUIDANCE THAT MAY ASSIST YOU DURING SCREENING.
EVENTUALLY, PLEASE FOLLOW THE DOSING PRESCRIBED BY OUR
PAEDIATRIC ID (Infectious Disease) TEAM.
FOR HEALTHCARE PROFESSIONAL USE ONLY
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.